Further to the posts already made by Reg, Col et al re Vinay Prasad, newly appointed head of CBER, one ought not underestimate what appears to be considerable respect shown by Prasad towards Philip Krause, coupled with the quality of the peer reviewed papers characterising the effect of Revascor on stage 2/3 patients with cardiac ischemia, which in my view only aligns with the level of rigour the likes of Prasad will be expecting
I attach a link to a couple of video's and posts from Prasad that may be of interest to others as it relates to commentary by Prasad on Krause and lastly a link to a 9 point plan by Prasad for health care reform...some of which you will note have already been enacted
In my view only, SI deserves some recognition at least for relationship/appointment of Krause...even though I too would welcome more material updates to enable the sp to capture the true value of the paradigm shift in treatment of inflammatory diseases being pionered by MSB .
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)